MHRA – Page 188 – Pharma.Tips

Tube Leakage Complaint during method transfer: QMS trending and complaint handling expectations

Addressing Tube Leakage Complaints During Method Transfers: Best Practices for Quality Management Systems Complaints regarding tube leakage during method transfers can significantly disrupt pharmaceutical manufacturing processes, especially for dosage forms…

Em Excursion after packaging change: sampling, filtration, and EM controls

Deviations Related to Em Excursion Following Packaging Changes: An In-depth Investigation Guide In the pharmaceutical industry, adherence to strict quality standards is paramount. An excursion in microbial contamination levels, particularly…

Pet Failure during inspection readiness: QMS trending and complaint handling expectations

Understanding Pet Failure During Inspection Readiness: Insights into QMS Trending and Complaint Management In the high-stakes environment of pharmaceutical manufacturing, being prepared for inspections is paramount. A common issue that…

Fill Weight Variability after supplier change: QMS trending and complaint handling expectations

Exploring Fill Weight Variability Following a Supplier Change: A Comprehensive Investigation Guide In pharmaceutical manufacturing, maintaining product quality is essential, and any deviations can significantly impact regulatory compliance and patient…

Suppository Deformation during bulk hold: CAPA with effectiveness checks for auditors

Addressing Suppository Deformation Issues During Bulk Hold: A Comprehensive CAPA Approach In the realm of pharmaceutical manufacturing, maintaining the integrity of product forms is vital. One such challenge arises with…

Particulate Matter Oos during method transfer: packaging integrity and CCIT justification

Investigation of Particulate Matter OOS During Method Transfer: Assessing Packaging Integrity and CCIT Justifications Issues related to particulate matter Out of Specification (OOS) results during method transfers can pose significant…

Pet Failure at accelerated stability: CAPA with effectiveness checks for auditors

Addressing Pet Failures in Accelerated Stability: An Investigation Guide for Pharma Professionals Pet failures during accelerated stability testing represent a significant challenge within pharmaceutical manufacturing, particularly for dosage forms such…

Melting Point Failure in suppository manufacturing: CAPA with effectiveness checks for auditors

Addressing Melting Point Failures in Suppository Manufacturing: A Comprehensive CAPA Guide In the pharmaceutical manufacturing landscape, maintaining product quality is paramount, particularly when it comes to dosage forms like suppositories.…

Sterility Test Failure for multi-dose products: CAPA and effectiveness check plan

Sterility Test Failures in Multi-Dose Products: Understanding the CAPA Process Sterility test failures in multi-dose products pose significant challenges to pharmaceutical manufacturers, especially within the ophthalmic dosage form sector. These…

Pet Failure after temperature excursion: CAPA with effectiveness checks for auditors

Addressing Pet Failure from Temperature Excursions: Effective CAPA for Auditors In the pharmaceutical manufacturing sector, deviations such as Pet Failure after temperature excursion can pose significant challenges in product quality…

Pet Failure after excipient change: packaging integrity and stability justification

Investigating Pet Failure Following an Excipient Change in Pharmaceutical Manufacturing Pharmaceutical manufacturers often face challenges when introducing new excipients in formulation processes, particularly with sensitive dosage forms such as rectal…

Microbial Limits Failure in suppository manufacturing: GMP investigation and batch disposition

Understanding the Investigation Process for Microbial Limits Failure in Suppository Manufacturing Microbial limits failure during the manufacturing of suppositories can lead to significant regulatory scrutiny and potential product recalls. Such…